Articles de revues sur le sujet « Experimental autoimmune encephalomyelitis, mast cells, histamine »
Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres
Consultez les 32 meilleurs articles de revues pour votre recherche sur le sujet « Experimental autoimmune encephalomyelitis, mast cells, histamine ».
À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.
Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.
Parcourez les articles de revues sur diverses disciplines et organisez correctement votre bibliographie.
Dietsch, G. N., and D. J. Hinrichs. "The role of mast cells in the elicitation of experimental allergic encephalomyelitis." Journal of Immunology 142, no. 5 (1989): 1476–81. http://dx.doi.org/10.4049/jimmunol.142.5.1476.
Texte intégralMusio, Silvia, Massimo Costanza, Pietro Luigi Poliani та ін. "Treatment with anti-FcεRIα antibody exacerbates EAE and T-cell immunity against myelin". Neurology - Neuroimmunology Neuroinflammation 4, № 3 (2017): e342. http://dx.doi.org/10.1212/nxi.0000000000000342.
Texte intégralCostanza, Massimo, Mario Colombo, and Rosetta Pedotti. "Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis." International Journal of Molecular Sciences 13, no. 12 (2012): 15107–25. http://dx.doi.org/10.3390/ijms131115107.
Texte intégralYin, Jun-Jie, Xue-Qiang Hu, Zhi-Feng Mao, et al. "Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis." Chinese Medical Journal 130, no. 8 (2017): 964–71. http://dx.doi.org/10.4103/0366-6999.204110.
Texte intégralElieh-Ali-Komi, Daniel, and Yonghao Cao. "Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis." Clinical Reviews in Allergy & Immunology 52, no. 3 (2016): 436–45. http://dx.doi.org/10.1007/s12016-016-8595-y.
Texte intégralRussi, Abigail E., Mark E. Ebel, Yuchen Yang, and Melissa A. Brown. "Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility." Proceedings of the National Academy of Sciences 115, no. 7 (2018): E1520—E1529. http://dx.doi.org/10.1073/pnas.1710401115.
Texte intégralHatfield, Julianne, and Melissa Brown. "The meninges: A staging site for immune cell interactions in early experimental autoimmune encephalomyelitis (P4166)." Journal of Immunology 190, no. 1_Supplement (2013): 172.10. http://dx.doi.org/10.4049/jimmunol.190.supp.172.10.
Texte intégralTeuscher, Cory, Meena Subramanian, Rajkumar Noubade, et al. "Central Histamine H3 Receptor Signaling Negatively Regulates Autoimmune Inflammation (129.31)." Journal of Immunology 178, no. 1_Supplement (2007): S223. http://dx.doi.org/10.4049/jimmunol.178.supp.129.31.
Texte intégralSecor, Virginia H., W. Evan Secor, Claire-Anne Gutekunst, and Melissa A. Brown. "Mast Cells Are Essential for Early Onset and Severe Disease in a Murine Model of Multiple Sclerosis." Journal of Experimental Medicine 191, no. 5 (2000): 813–22. http://dx.doi.org/10.1084/jem.191.5.813.
Texte intégralORR, EDWARD L. "Presence and Distribution of Nervous System-Associated Mast Cells That May Modulate Experimental Autoimmune Encephalomyelitis." Annals of the New York Academy of Sciences 540, no. 1 Advances in N (1988): 723–26. http://dx.doi.org/10.1111/j.1749-6632.1988.tb27226.x.
Texte intégralOrr, Edward L. "Presence and distribution of nervous system — associated mast cells which may modulate experimental autoimmune encephalomyelitis." Journal of Neuroimmunology 16, no. 1 (1987): 136. http://dx.doi.org/10.1016/0165-5728(87)90341-9.
Texte intégralBicer, Fuat, Cengiz Z. Altuntas, Kenan Izgi, et al. "Chronic pelvic allodynia is mediated by CCL2 through mast cells in an experimental autoimmune cystitis model." American Journal of Physiology-Renal Physiology 308, no. 2 (2015): F103—F113. http://dx.doi.org/10.1152/ajprenal.00202.2014.
Texte intégralDesbiens, Louisane, Catherine Lapointe, Marjan Gharagozloo, et al. "Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis." Mediators of Inflammation 2016 (2016): 1–10. http://dx.doi.org/10.1155/2016/9797021.
Texte intégralWeiskirchen, Ralf, Steffen K. Meurer, Christian Liedtke, and Michael Huber. "Mast Cells in Liver Fibrogenesis." Cells 8, no. 11 (2019): 1429. http://dx.doi.org/10.3390/cells8111429.
Texte intégralBrown, Melissa Ann, and Yuchen Yang. "Distinct chromatin modifications at the Il33 locus in mast cells contribute to sex dimorphic susceptibility to EAE, an autoimmune CNS demyelinating disease." Journal of Immunology 204, no. 1_Supplement (2020): 219.8. http://dx.doi.org/10.4049/jimmunol.204.supp.219.8.
Texte intégralSaligrama, Naresha, Rajkumar Noubade, Laure Case, Matthew Poynter, and Cory Teuscher. "H1R signaling in antigen presenting cells is dispensable for eliciting pathogenic T cells in experimental allergic encephalomyelitis (123.14)." Journal of Immunology 188, no. 1_Supplement (2012): 123.14. http://dx.doi.org/10.4049/jimmunol.188.supp.123.14.
Texte intégralAldossari, Abdullah A., Mohammed A. Assiri, Mushtaq A. Ansari, et al. "Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance." International Journal of Molecular Sciences 24, no. 20 (2023): 15273. http://dx.doi.org/10.3390/ijms242015273.
Texte intégralFinlay, Conor M., Kyle T. Cunningham, Benjamin Doyle, and Kingston H. G. Mills. "IL-33–Stimulated Murine Mast Cells Polarize Alternatively Activated Macrophages, Which Suppress T Cells That Mediate Experimental Autoimmune Encephalomyelitis." Journal of Immunology 205, no. 7 (2020): 1909–19. http://dx.doi.org/10.4049/jimmunol.1901321.
Texte intégralShi, Yaru, Zhenlong Li, Ran Chen, et al. "Immethridine, histamine H3-receptor (H3R) agonist, alleviated experimental autoimmune encephalomyelitis via inhibiting the function of dendritic cells." Oncotarget 8, no. 43 (2017): 75038–49. http://dx.doi.org/10.18632/oncotarget.20500.
Texte intégralBrown, Melissa Ann, and Yuchen Yang. "Distinct chromatin modifications at the Il33 locus in mast cells contribute to sex dimorphic susceptibility to EAE, an autoimmune CNS demyelinating disease." Journal of Immunology 206, no. 1_Supplement (2021): 64.15. http://dx.doi.org/10.4049/jimmunol.206.supp.64.15.
Texte intégralNowak, Elizabeth C., Casey T. Weaver, Henrietta Turner, et al. "IL-9 as a mediator of Th17-driven inflammatory disease." Journal of Experimental Medicine 206, no. 8 (2009): 1653–60. http://dx.doi.org/10.1084/jem.20090246.
Texte intégralHong, Gwan Ui, Young Min Ahn, and Jai Youl Ro. "Transglutaminase 2 over-Expressed By Interaction of Mast Cells and Oligodendrocytes Induces Demyelination in the Experimental Autoimmune Encephalomyelitis." Journal of Allergy and Clinical Immunology 137, no. 2 (2016): AB76. http://dx.doi.org/10.1016/j.jaci.2015.12.257.
Texte intégralPiconese, Silvia, Giorgia Gri, Claudio Tripodo, et al. "Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation." Blood 114, no. 13 (2009): 2639–48. http://dx.doi.org/10.1182/blood-2009-05-220004.
Texte intégralNoubade, Rajkumar, Mercedes Rincon, and Cory Teuscher. "IFN-gamma production by CD4 T cells requires Histamine H1 receptor during their initial phase of activation (87.25)." Journal of Immunology 178, no. 1_Supplement (2007): S132. http://dx.doi.org/10.4049/jimmunol.178.supp.87.25.
Texte intégralPiacente, Francesco, Marta Bottero, Andrea Benzi, et al. "Neuroprotective Potential of Dendritic Cells and Sirtuins in Multiple Sclerosis." International Journal of Molecular Sciences 23, no. 8 (2022): 4352. http://dx.doi.org/10.3390/ijms23084352.
Texte intégralLee, Sung Won, Hyun Jung Park, Jungmin Jeon, et al. "Ubiquitous Overexpression of Chromatin Remodeling Factor SRG3 Exacerbates Atopic Dermatitis in NC/Nga Mice by Enhancing Th2 Immune Responses." International Journal of Molecular Sciences 22, no. 4 (2021): 1553. http://dx.doi.org/10.3390/ijms22041553.
Texte intégralBennett, Jami L., Marie-Renée Blanchet, Linlin Zhao, et al. "Bone Marrow-Derived Mast Cells Accumulate in the Central Nervous System During Inflammation but Are Dispensable for Experimental Autoimmune Encephalomyelitis Pathogenesis." Journal of Immunology 182, no. 9 (2009): 5507–14. http://dx.doi.org/10.4049/jimmunol.0801485.
Texte intégralNowak, Elizabeth C., Victor C. de Vries, Anna Wasiuk, et al. "Tryptophan hydroxylase-1 regulates immune tolerance and inflammation." Journal of Experimental Medicine 209, no. 11 (2012): 2127–35. http://dx.doi.org/10.1084/jem.20120408.
Texte intégralHong, Gwan Ui, Nam Goo Kim, Dooil Jeoung, and Jai Youl Ro. "Anti-CD40 Ab- or 8-oxo-dG-enhanced Treg cells reduce development of experimental autoimmune encephalomyelitis via down-regulating migration and activation of mast cells." Journal of Neuroimmunology 260, no. 1-2 (2013): 60–73. http://dx.doi.org/10.1016/j.jneuroim.2013.04.002.
Texte intégralAlsaad, Abdulaziz M. S., Mushtaq A. Ansari, Ahmed Nadeem, et al. "Histamine H4 Receptor Agonist, 4-Methylhistamine, Aggravates Disease Progression and Promotes Pro-Inflammatory Signaling in B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model." International Journal of Molecular Sciences 24, no. 16 (2023): 12991. http://dx.doi.org/10.3390/ijms241612991.
Texte intégralShort, Abigail, Margaret Walker-Caulfield, and Melissa Brown. "c-kit signaling pathways regulate EAE susceptibility in male SJL mice (P3119)." Journal of Immunology 190, no. 1_Supplement (2013): 43.21. http://dx.doi.org/10.4049/jimmunol.190.supp.43.21.
Texte intégralAlrashdi, Barakat, Bassel Dawod, Sabine Tacke, Stefanie Kuerten, Patrice D. Côté, and Jean S. Marshall. "Mice Heterozygous for the Sodium Channel Scn8a (Nav1.6) Have Reduced Inflammatory Responses During EAE and Following LPS Challenge." Frontiers in Immunology 12 (March 19, 2021). http://dx.doi.org/10.3389/fimmu.2021.533423.
Texte intégral